Conclusion from a prospective study in 2019 demonstrated that in summary, folate, vitamin B12, vitamin B6, homocysteine, and cysteine levels are independently associated with breast cancer risk, regardless of in situ/invasive, hormone receptor status, or tumor molecular subtype (Houghton et al., 2019). The gene discussed is NR4A1; the disease is breast cancer.